1-3 of 3
Chaher Alhandalous, MD
Close
Sort by
Journal Articles

Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Xu Zhang, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Johara Hassan, MD, Chaher Alhandalous, MD, Jewel Younge, MA, Taimur Abbasi, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD
Journal: Blood
Blood (2015) 126 (23): 3400.
https://doi.org/10.1182/blood.V126.23.3400.3400
Published: 2015
Journal Articles

Combination with Thu to Address Pharmacologic Limitations of Decitabine, Interim PK/PD from a Phase 1/2 Clinical Trial of Oral Thu-Decitabine in Sickle Cell Disease

Donald Lavelle, PhD, Michel Gowhari, DO, Michael Pacini, PharmD, Lani Krauz, RN, Johara Hassan, MD, Vinzon Ibanez, Maria A. Ruiz, MSc, Daisy Pacelli, BSc, Chaher Alhandalous, MD, Mitch A. Phelps, PhD, Kathleen Fenner, BS,MS, Reda Z. Mahfouz, MDPhD, John Barnard, Lewis L. Hsu, MD PhD, Victor R. Gordeuk, MD, Joseph DeSimone, PhD, Yogen Saunthararajah, MD, Robert E. Molokie, MD
Journal: Blood
Blood (2014) 124 (21): 90.
https://doi.org/10.1182/blood.V124.21.90.90
Published: 2014
Journal Articles

Age As an Independent Clinical Predictor for Vitamin D Deficiency in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Taimur Abbasi, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Johara Hassan, MD, Michel Gowhari, DO, Chaher Alhandalous, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD
Journal: Blood
Blood (2014) 124 (21): 1385.
https://doi.org/10.1182/blood.V124.21.1385.1385
Published: 2014